BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Management Shakeup at Cash-Strapped Presbia, New Leader Named

  The company also received an investment proposal from Orchard Capital Corporation to invest up to $5 million in the Company’s preferred shares.

  December 14, 2017

   · 

  4 min read
• Biotech Beach

  San Diego’s AmpliPhi Biosciences Is Reviewing Strategic Alternatives

  AmpliPhi Biosciences announced its progress in 2017 and near-term strategic goals and initiatives.

  December 14, 2017

   · 

  7 min read
• Policy

  CanniMed Therapeutics Receives Municipal Approval from Carp Lake Township to Apply for State of Michigan Licenses for Medical Cannabis Production and Processing

  The Company intends to submit an application for a Class C Grower License as well as a Processor License to the State of Michigan on or about the opening of the application period, December 15, 2017.

  December 14, 2017

   · 

  5 min read
• Genetown

  Verastem Announces Public Offering of Common Stock

  Verastem announced that it intends to offer and sell $25 million of its common stock in an underwritten public offering.

  December 14, 2017

   · 

  3 min read
• 

  FDA

  Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis

  The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.

  December 14, 2017

   · 

  18 min read
• Drug Development

  AveXis Announces Plan to Initiate Phase I Trial in SMA Type II Utilizing Intrathecal Delivery of AVXS-101

  The company plans to initiate this trial immediately.

  December 14, 2017

   · 

  10 min read
• Business

  AlloSource Announces Raime Leeby Muhle as CFO

  With over 18 years of experience, Leeby Muhle’s background spans from emerging high growth businesses to large and mature organizations.

  December 14, 2017

   · 

  2 min read
• BIC Launches New Report to Help Bioeconomy Projects Access Finance

  The BIC has released a new overview of financial instruments available to support European bioeconomy development.

  December 14, 2017

   · 

  1 min read
• Pharm Country

  Tauriga Sciences Fully Repays $80,000 USD 5% Face Value Convertible Debenture Issued to GS Capital Partners, LLC on June 27, 2017 for One Time Cash Payment of $108,164.38 USD

  This convertible debenture, which was issued by the Company on June 27, 2017, has been fully repaid for a one-time cash payment of $108,164.38 USD. Accordingly, this debt has been removed from the Company’s balance sheet.

  December 14, 2017

   · 

  3 min read
• Policy

  Shire’s New Formulation of ONCASPAR (pegaspargase) Receives Marketing Authorization in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)

  Shire today announced that the European Commission granted Marketing Authorization for lyophilized ONCASPAR, as a component of antineoplastic combination therapy in acute lymphoblastic leukemia in pediatric patients from birth to 18 years, and in adult patients.

  December 14, 2017

   · 

  4 min read